A panel of leading investors gathers Tel Aviv for “Life Science Funds Forum” with the newspaper origins, and the new newspaper challenges, and the development of the challenges of structure, and the development of challenges In structuring, and new models of newspaper, and the development of structural challenges, and the development of structural challenges, and the development of the entrepreneur’s challenges, and the new models of traders are between entrepreneurs among entrepreneurs between businessmen’s traders and investors. The panel, with the title “Life science change: funding strategies in a changing market,” administered in adv. Gary Copelovitz, co-head with the Lipa Meir Law firm.
“The name of the game is planning, planning ahead,” says Copelovitz in a message to traders. “It all depends on your needs and the stage you are at – but the key is to plan ahead.
“Preventing standard funding funds is as important as raising funds. Copelovitz.,” You can achieve three main goals: Keep your path to your lid on your lid. That is triumvirate every start. “
Beating the iluses
Michel Habib, Cofounder and General Partner in the Live HealthTech Fund, shares his views on financial and investment expectations.
Habib said, “Some entrepreneurs have an illusion that they can reach an exit with 51% to start a starting company.
“So the ability to raise money is not only technology is good and the quality of traders and their experience, than the product or business strategy.”
Focus on R & D
Copelovitz asked the Peregrine Ventures Partner, Director of Investor Relations, Business Developmental Tal Carmasso about Ascuntiogan Ravavace Audgmation.
Carmasso said, “In some cases, founder for the first time no idea how to run a company.
Low Israelis Price
Yael Grubenbaum-Cohen, partner of Amoon, exposed to make investment investment in Israeli market today.
Gruenbaum-Cohen said, “The prices here are very low. For companies, many times for a year. We’re the Powerpoint presentation to us. We’re going to be a big deal with us. If you’re not going well with us.
Public-Private Partnership
Inbar Blum, Director of planning, development and development of ISONSO Rovavae AWATION AUTHORITE, how has the authority involved in private investors to support the start stage.
Blum said, “If you apply to get funds, there are auditors to come and check your combination. You need these investors as well.
Transfer to the US
Finally Copelovitz asked Amir Blatt, gathering partner and CEO Almeda efforts at which time must be transferred to Israel in the US.
Blatt said, “In a place in the $ 1 million sale is the stage where I want the CEO later in Israel. Biotech, I hope it got it before that.”
Published in Globes, Israel News in News – en.globes.co.il – On June 9, 2025.
© Copyright in Globes Publisher Itonut (1983) Ltd., 2025.
